On January 6, according to information from the Securities Regulatory Commission, Deshi Biotech obtained a “full circulation” filing notice for overseas issued and listed shares and domestic unlisted shares from the Securities Regulatory Commission.

Zhitongcaijing · 5d ago
On January 6, according to information from the Securities Regulatory Commission, Deshi Biotech obtained a “full circulation” filing notice for overseas issued and listed shares and domestic unlisted shares from the Securities Regulatory Commission.